Get the Stockscreener App
0.6762
4.76%
-0.0338
Moolec Science Sa stock is traded at $0.6762, with a volume of 9,574.
It is down -4.76% in the last 24 hours and down -19.68% over the past month.
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.
See More
Previous Close:
$0.71
Open:
$0.71
24h Volume:
9,574
Relative Volume:
0.57
Market Cap:
$28.80M
Revenue:
$5.63M
Net Income/Loss:
$-7.31M
P/E Ratio:
-3.381
EPS:
-0.2
Net Cash Flow:
$-9.49M
1W Performance:
+8.59%
1M Performance:
-19.68%
6M Performance:
-24.02%
1Y Performance:
-52.04%
1-Day Range:
$0.6192
$0.7169
1-Week Range:
$0.5542
$0.7356
52-Week Range:
$0.53
$3.25
Moolec Science Sa Stock (MLEC) Company Profile
Compare MLEC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MLEC
Moolec Science Sa
|
0.6762 | 28.80M | 5.63M | -7.31M | -9.49M | -0.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
489.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.16 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
596.20 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
234.56 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Moolec Science Sa Stock (MLEC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-27-23 | Initiated | ROTH MKM | Buy |
Moolec Science Sa Stock (MLEC) Latest News
Moolec Science Announces Business Combination - Investing.com Australia
Moolec Science Announces Business Combination By Investing.com - Investing.com South Africa
Moolec Science Announces Strategic Business Combination with Bioceres Group - TipRanks
Moolec Science (NASDAQ:MLEC) Trading Down 1.2% – What’s Next? - Defense World
Moolec Science SA reports results for the quarter ended December 31Earnings Summary - TradingView
Moolec Science Reports Financial Results for December 2024 - TipRanks
Leadership Changes at Moolec Science as CEO and Board Members Resign - TipRanks
Moolec Science Plans Strategic Relocation and Board Appointments - TipRanks
Moolec Science receives Nasdaq compliance extension By Investing.com - Investing.com Australia
Moolec Science Granted Temporary Nasdaq Compliance Exception - TipRanks
Moolec Science receives Nasdaq compliance extension - Investing.com
Moolec Science (NASDAQ:MLEC) Stock Price Up 5% – Should You Buy? - Defense World
Quantum FinTech Acquisition (NYSE:QFTA) and Moolec Science (NASDAQ:MLEC) Financial Contrast - Defense World
Moolec Received Nasdaq Staff Determination Letter - Big News Network
Press Release Distribution & PR Platform - ACCESS Newswire
Nasdaq Threatens Moolec Delisting: Company's Last-Minute Strategy to Save Its Listing - Stock Titan
Moolec Science Appeals Nasdaq Delisting Notice - MSN
Moolec Science faces Nasdaq delisting over share price By Investing.com - Investing.com Australia
Moolec Science faces Nasdaq delisting over share price - Investing.com
Moolec Science (MLEC) Stock Price, News & Analysis - MarketBeat
Moolec Science (MLEC) Expected to Announce Quarterly Earnings on Tuesday - Defense World
Moolec Science Presents Third Quarter Fiscal Year 2024 Business Update - ACCESS Newswire
Why Shares Of Moolec Science Are Skyrocketing Today - MSN
Evergreen (NASDAQ:EVGR) and Moolec Science (NASDAQ:MLEC) Head-To-Head Analysis - Defense World
Reviewing Moolec Science (NASDAQ:MLEC) & Brooge Energy (NASDAQ:BROG) - Defense World
Moolec Science Presents Third Quarter FY 2023 Business Update - ACCESS Newswire
Moolec Science to Host First Quarter Fiscal Year 2024 Business Update Conference Call - ACCESS Newswire
Moolec Science (NASDAQ:MLEC) Shares Down 0.1% – What’s Next? - Defense World
Moolec Science Reports Financial Results Showing Decline - TipRanks
MLEC Stock Touches 52-Week Low at $0.75 Amid Market Challenges - Investing.com India
Moolec Science Presents 'Piggy Sooy', a Soybean Platform That Can Produce Significantly High Amounts of Pork Proteins - ACCESS Newswire
Moolec Signs an Offtake Agreement With Major Global CPG Company to Hit the US Market in 2025 - ACCESS Newswire
Moolec Science Secures Up to $50 Million in Committed Equity Financing With Nomura - ACCESS Newswire
Moolec Becomes First Molecular Farming Company to Achieve USDA Approval for Plant-Grown Animal Proteins - ACCESS Newswire
Moolec Science to Host Fourth Quarter Fiscal Year 2024 Business Update Conference Call - ACCESS Newswire
Moolec Science to Host Third Quarter Fiscal Year 2024 Business U - GuruFocus.com
Moolec Science SA approves relocation to Cayman Islands - Investing.com India
Moolec Science SA approves relocation to Cayman Islands By Investing.com - Investing.com Australia
Moolec Science (NASDAQ:MLEC) versus Target Global Acquisition I (NASDAQ:TGAA) Critical Contrast - Defense World
Moolec Science (NASDAQ:MLEC) Is Making Moderate Use Of Debt - Simply Wall St
Moolec Science Announces AGM and EGM with Key Resolutions - TipRanks
Moolec Science (NASDAQ:MLEC) Stock Price Down 1.3% – What’s Next? - Defense World
Moolec Science Sa Stock (MLEC) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):